Ligand validation:6RT2

CV5: (3~{S})-3-[[1-(2-hydroxyethyl)-5-[(4-methoxynaphthalen-1-yl)methyl]-6,7-dihydro-4~{H}-pyrazolo[4,3-c]pyridin-3-yl]carbonylamino]-3-phenyl-propanoic acid

CV5 is a Ligand Of Interest in 6RT2 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6RT2_CV5_C_101	85%	6%	0.074	0.937	2.69	2.37	17	14	0	0	100%	1
6RT2_CV5_A_101	79%	9%	0.075	0.919	2.37	2.16	10	11	0	0	100%	1
6RT2_CV5_B_101	75%	2%	0.081	0.914	3.11	3.69	20	24	0	0	100%	1
6RT2_CV5_D_101	47%	4%	0.115	0.851	2.84	2.66	19	17	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.